Total Assets for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported total assets is $90.04B USD. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and net assets for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal AssetsSwitch metric
Latest period
$90.04B
YoY change
-2.8%
5Y CAGR
-5.3%
Peak year (2019)
$129.94B
Latest annual
$90.04B
Total Assets history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Total Assets history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | Total Assets | YoY |
|---|---|---|---|---|
| 2025 | $90.04B | -2.8% | ||
| 2024 | $92.60B | -2.7% | ||
| 2023 | $95.16B | -1.7% | ||
| 2022 | $96.82B | -11.4% | ||
| 2021 | $109.31B | -7.7% | ||
| 2020 | $118.48B | -8.8% | ||
| 2019 | $129.94B | +271.4% | ||
| 2018 | $34.99B | +4.3% | ||
| 2017 | $33.55B | -0.5% | ||
| 2016 | $33.71B | +6.2% | ||
| 2015 | $31.75B | -5.9% | ||
| 2014 | $33.75B | -12.5% | ||
| 2013 | $38.59B | +7.5% | ||
| 2012 | $35.90B | +8.9% | ||
| 2011 | $32.97B | +6.1% | ||
| 2010 | $31.08B | +0.2% | ||
| 2009 | $31.01B | +5.2% | ||
| 2008 | $29.49B | +12.7% | ||
| 2007 | $26.17B | +2.3% | ||
| 2006 | $25.57B | -9.1% | ||
| 2005 | $28.14B | -7.5% | ||
| 2004 | $30.43B | +10.9% | ||
| 2003 | $27.45B | +9.7% | ||
| 2002 | $25.02B | -10.0% | ||
| 2001 | $27.81B | +58.2% | ||
| 2000 | $17.58B | +2.7% | ||
| 1999 | $17.11B | +5.2% | ||
| 1998 | $16.27B | +8.6% | ||
| 1997 | $14.98B | +2.0% | ||
| 1996 | $14.69B | +5.4% | ||
| 1995 | $13.93B | +7.9% | ||
| 1994 | $12.91B | +6.7% | ||
| 1993 | $12.10B | +12.0% | ||
| 1992 | $10.80B | +14.7% | ||
| 1991 | $9.42B | +2.2% | ||
| 1990 | $9.21B | +8.5% | ||
| 1989 | $8.50B | +2.7% | ||
| 1988 | $8.27B | +10.1% | ||
| 1987 | $7.51B | — |
Total Assets values are taken from Bristol-Myers Squibb's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Bristol-Myers Squibb (BMY) reported total assets of $90.04B – edged down 2.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Bristol-Myers Squibb total assets compounded at -5.3% per year, with a net decline across the window.
Bristol-Myers Squibb total assets peaked at $129.94B in 2019; the latest annual figure is $90.04B in 2025 (30.7% below peak).
The dataset's maximum total assets sits at $129.94B (2019); the minimum reading of $7.51B dates to 1987.
Within Healthcare, Bristol-Myers Squibb (BMY) ranks 9th among 8 peers we track. The peer median for total assets is $135.41B.
Bristol-Myers Squibb Total Assets by Year
Bristol-Myers Squibb Total Assets 2025: $90.04B
Bristol-Myers Squibb total assets in 2025 was $90.04B, edged down 2.8% below 2024.
Bristol-Myers Squibb Total Assets 2024: $92.60B
Bristol-Myers Squibb total assets in 2024 was $92.60B, edged down 2.7% below 2023.
Bristol-Myers Squibb Total Assets 2023: $95.16B
Bristol-Myers Squibb total assets in 2023 was $95.16B, edged down 1.7% below 2022.
Bristol-Myers Squibb Total Assets 2022: $96.82B
Bristol-Myers Squibb total assets in 2022 was $96.82B, declined 11.4% below 2021.
Bristol-Myers Squibb Total Assets 2021: $109.31B
Bristol-Myers Squibb total assets in 2021 was $109.31B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Total Assets
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest total assets.
| Company | Total Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $542.90B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $309.58B | Healthcare |
| Johnson & Johnson (JNJ) | $199.21B | Healthcare |
| Merck & Co., Inc. (MRK) | $136.87B | Healthcare |
| AbbVie Inc. (ABBV) | $133.96B | Healthcare |
| AstraZeneca PLC (AZN) | $114.07B | Healthcare |
| Eli Lilly and Company (LLY) | $112.48B | Healthcare |
| Amgen Inc. (AMGN) | $90.59B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's total assets?
- Latest reported total assets for Bristol-Myers Squibb (BMY) is $90.04B (period ending December 31, 2025).
How has Bristol-Myers Squibb total assets changed year-over-year?
- Bristol-Myers Squibb (BMY) total assets changed -2.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb total assets?
- Bristol-Myers Squibb (BMY) total assets compound annual growth rate is -5.3% over the most recent 5 years available.
When did Bristol-Myers Squibb total assets hit its highest annual value?
- Bristol-Myers Squibb total assets reached its highest annual value of $129.94B in 2019.
What was Bristol-Myers Squibb total assets in 2024?
- Bristol-Myers Squibb (BMY) total assets in 2024 was $92.60B.
What was Bristol-Myers Squibb total assets in 2025?
- Bristol-Myers Squibb (BMY) total assets in 2025 was $90.04B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.